Nature Neuroscience, Journal Year: 2025, Volume and Issue: unknown
Published: March 11, 2025
Language: Английский
Nature Neuroscience, Journal Year: 2025, Volume and Issue: unknown
Published: March 11, 2025
Language: Английский
Cell, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 1, 2025
Language: Английский
Citations
22Neuron, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 1, 2025
Continuous sleep restores the brain and body, whereas fragmented harms cognition health. Microarousals (MAs), brief (3- to 15-s-long) wake intrusions into sleep, are clinical markers for various disorders. Recent rodent studies show that MAs during healthy non-rapid eye movement (NREM) driven by infraslow fluctuations of noradrenaline (NA) in coordination with electrophysiological rhythms, vasomotor activity, cerebral blood volume, glymphatic flow. hence part dynamics, raising questions about their biological roles. We propose bolster NREM sleep's benefits associated NA fluctuations, according an inverted U-shaped curve. Weakened noradrenergic as may occur neurodegenerative diseases or aids, reduce MAs, exacerbated caused stress fragment collapse signaling. suggest crucial restorative plasticity-promoting functions advance our insight normal pathological arousal dynamics from sleep.
Language: Английский
Citations
5Neurobiology of Disease, Journal Year: 2025, Volume and Issue: 205, P. 106791 - 106791
Published: Jan. 6, 2025
Neurodegenerative diseases (ND) are characterized by the accumulation of aggregated proteins. The glymphatic system, through its rapid exchange mechanisms between cerebrospinal fluid (CSF) and interstitial (ISF), facilitates movement metabolic substances within brain, serving functions akin to those peripheral lymphatic system. This emerging waste clearance mechanism offers a novel perspective on removal pathological in ND. article elucidates recent discoveries regarding system updates relevant concepts model. It discusses potential roles ND, including Alzheimer's disease (AD), Parkinson's (PD), multiple atrophy (MSA), proposes as therapeutic target for these conditions.
Language: Английский
Citations
2Molecular Psychiatry, Journal Year: 2024, Volume and Issue: unknown
Published: Aug. 11, 2024
In the context of escalating global health challenge posed by Alzheimer's disease (AD), this comprehensive review considers potential melatonin in both preventive and therapeutic capacities. As a naturally occurring hormone robust antioxidant, accumulating evidence suggests is compelling candidate to consider AD-related pathologies. The several mechanisms, including effects on amyloid-beta pathologic tau burden, antioxidant defense, immune modulation, regulation circadian rhythms. Despite its promise, gaps need be addressed prior clinical translation. These include conducting additional randomized trials patients with or at risk for AD dementia, determining optimal dosage timing, further side effects, particularly long-term use. This consolidates existing knowledge, identifies gaps, directions future research better understand neuroprotection mitigation within landscape AD.
Language: Английский
Citations
11bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown
Published: Aug. 26, 2024
We here revisited the concept that glymphatic clearance is enhanced by sleep and anesthesia. Utilizing dynamic magnetic resonance imaging (MRI), single photon emission computed tomography (SPECT), fluorescent fiber photometry, we report brain both anesthesia, sharply suppressed wakefulness. Another key finding was less tracer enters brains of awake animals across different states can only be compared after adjusting for injected dose.
Language: Английский
Citations
10Neurotherapeutics, Journal Year: 2025, Volume and Issue: unknown, P. e00535 - e00535
Published: Jan. 1, 2025
Language: Английский
Citations
1Nature Neuroscience, Journal Year: 2025, Volume and Issue: unknown
Published: March 11, 2025
Language: Английский
Citations
1Neuron, Journal Year: 2024, Volume and Issue: 112(14), P. 2349 - 2367.e8
Published: May 22, 2024
Language: Английский
Citations
7The Lancet Neurology, Journal Year: 2024, Volume and Issue: 24(1), P. 20 - 22
Published: Dec. 18, 2024
Language: Английский
Citations
5Ageing Research Reviews, Journal Year: 2024, Volume and Issue: unknown, P. 102514 - 102514
Published: Sept. 1, 2024
Language: Английский
Citations
4